Skip to main content
Premium Trial:

Request an Annual Quote

454, Baylor Complete Sequence of Watson's Genome; Cost Breaks $1M Mark

NEW YORK (GenomeWeb News) — 454 Life Sciences and the Human Genome Sequencing Center at Baylor College have finished sequencing, verifying, and annotating the genome of James Watson, the partners said today.
The project took two months and cost less than $1 million, the first human genome to break the $1 million mark, the company and the school said. 454 handled the sequencing and BCM verified and interpreted the data, Baylor said.
Michael Egholm, 454’s vice president of R&D, said the company performed the sequencing on its GS FLX systems and obtained “a near complete picture” of Watson’s genome. He also said the project identified “missing pieces of the public reference genome” generated by the Human Genome Project.
Watson will receive the sequence on a DVD at an event today at Baylor’s campus that will include speeches by Watson and representatives of 454 and BCM. He will decide what portions of his genomic information will be made public.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.